Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × dolastatin 10 × Clear all

NCT00003626 2013-04-05

Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms